The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages

Glucocorticoids are widely used to treat inflammatory disorders; however, prolonged use of glucocorticoids results in side effects including osteoporosis, diabetes and obesity. Compound A (CpdA), identified as a selective NR3C1/glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylka, Viacheslav, Deckers, Julie, Ratman, Dariusz, De Cauwer, Lode, Thommis, Jonathan, De Rycke, Riet, Impens, Francis, Libert, Claude, Tavernier, Jan, Vanden Berghe, Wim, Gevaert, Kris, De Bosscher, Karolien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper - Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984772/
https://www.ncbi.nlm.nih.gov/pubmed/30215534
http://dx.doi.org/10.1080/15548627.2018.1495681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984772/
https://www.ncbi.nlm.nih.gov/pubmed/30215534
http://dx.doi.org/10.1080/15548627.2018.1495681

Ejemplares similares